PharmaCyte Biotech
Quarterly Financials
| Values in thousands | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -2,118 | -1,376 | -8,360 | |
EBIT | -1,041 | -1,041 | ||
Net Income | 746 | -7,417 | -8,360 | 11,749 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -786 | -979 | -1,993 | -1,040 |
Cash | 20,165 | 15,406 | 13,178 | 15,172 |
Basic Shares | 9,262 | 6,795 | 6,795 | 6,795 |
Annual Financials
| Values in thousands | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | 30,656 | 6,853 | -4,316 | -4,239 |
EBIT | -4,377,862,000 | 333 | -10,771 | -8,631 |
Net Income | 30,656 | 333 | -4,316 | -4,239 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,978 | -2,151 | -3,793 | -4,117 |
Cash | 15,172 | 50,179 | 68,039 | 85,400 |
Basic Shares | 7,330 | 9,581 | 5,178 | 5,178 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-01-31 | -$0.16 |
2025-10-31 | -$1.24 |
2025-07-31 | -$1.23 |
2025-04-30 | $1.58 |
